Insider Selling: Trupanion, Inc. (NASDAQ:TRUP) CFO Sells $37,698.84 in Stock

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CFO Fawwad Qureshi sold 828 shares of the business's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $45.53, for a total transaction of $37,698.84. Following the completion of the transaction, the chief financial officer now owns 6,079 shares of the company's stock, valued at approximately $276,776.87. This trade represents a 11.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Trupanion Stock Down 2.0%

Shares of TRUP traded down $0.95 during mid-day trading on Friday, reaching $47.20. The company's stock had a trading volume of 780,380 shares, compared to its average volume of 609,064. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90. The stock has a market cap of $2.02 billion, a PE ratio of -205.22, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The company's 50 day moving average is $39.91 and its 200 day moving average is $43.86.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. During the same quarter last year, the company earned ($0.16) EPS. The business's quarterly revenue was up 11.7% on a year-over-year basis. Equities analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Institutional Investors Weigh In On Trupanion

Several hedge funds and other institutional investors have recently made changes to their positions in the business. SBI Securities Co. Ltd. purchased a new stake in Trupanion in the fourth quarter valued at $25,000. Jones Financial Companies Lllp lifted its position in Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock valued at $27,000 after acquiring an additional 238 shares during the last quarter. Quarry LP purchased a new stake in Trupanion in the fourth quarter valued at $39,000. AlphaQuest LLC lifted its position in Trupanion by 940.6% in the first quarter. AlphaQuest LLC now owns 1,051 shares of the financial services provider's stock valued at $39,000 after acquiring an additional 950 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd lifted its position in Trupanion by 988.5% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider's stock valued at $55,000 after acquiring an additional 1,028 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts have commented on TRUP shares. Piper Sandler dropped their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. Lake Street Capital dropped their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Finally, Stifel Nicolaus lowered their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $51.80.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.